Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

Back

HFA Premium Access

Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

Session: Registry Updates

Topic: Pharmacotherapy

Speaker: Doctor M. Vaduganathan (Boston, US)

Event: Heart Failure 2021

Congress Presentation

About the speaker

Doctor Muthiah Vaduganathan

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)

14 presentations

2 followers

10 more presentations in this session

SCD and ventricular event rates in a Japanese population: Primary results from the Heart Failure Indication and Sudden Cardiac Death Prevention Trial

Speaker: Doctor K. Aonuma (Tsukuba, JP)

Access

Slides

Video

Clinical course and related costs of patients with type 2 diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Speaker: Professor A. Maggioni (Florence, IT)

Access

Slides

Video

Potential Implications of Expanded FDA Labeling for Sacubitril/Valsartan in the United States

Speaker: Doctor M. Vaduganathan (Boston, US)

Access

Slides

Video

Higher Alkaline Phosphatase Mean and Variability Predict Heart Failure and All-cause Mortality

Speaker: Ms S. Lee (Shatin, HK)

Access

Slides

Video

Heart Failure Drug Titration, Discontinuation and Mortality and HF Hospitalization Risk: A Multinational Observational Study (US, UK and Sweden)

Speaker: Associate Professor G. Savarese (Stockholm, SE)

Access

Slides

Video

Access the full session

Registry Updates

Speakers: Doctor M. Vaduganathan, Doctor K. Aonuma, Professor A. Maggioni, Doctor M. Vaduganathan, Ms S. Lee...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

About the speaker

Doctor Muthiah Vaduganathan

10 more presentations in this session

SCD and ventricular event rates in a Japanese population: Primary results from the Heart Failure Indication and Sudden Cardiac Death Prevention Trial

Clinical course and related costs of patients with type 2 diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Potential Implications of Expanded FDA Labeling for Sacubitril/Valsartan in the United States

Higher Alkaline Phosphatase Mean and Variability Predict Heart Failure and All-cause Mortality

Heart Failure Drug Titration, Discontinuation and Mortality and HF Hospitalization Risk: A Multinational Observational Study (US, UK and Sweden)

Access the full session

Registry Updates

About the event

Heart Failure 2021

ESC 365 is supported by